An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Sponsor
Chimerix

Protocol Number
Chimerix CMX001-351

To Learn More Call
201-510-0910